Close to 100 million wearable, remote patient-monitoring devices will ship over the next five years, according to ABI Research, boosted by growing interest and awareness about the benefits of supporting healthcare away from the hospital and into patients’ homes.
Medivation and Astellas Pharma on Wednesday announced that the Food and Drug Administration approved a new use of Xtandi (enzalutamide) capsules to treat patients with metastatic castration-resistant prostate cancer.
The National Association of Boards of Pharmacy last week launched the .pharmacy generic Top-Level Domain (gTLD) to provide consumers a means for identifying safe, legal and ethical online pharmacies and related resources.
The Ohio-based start-up C2B Solutions is available to provide key healthcare consumer insights and strategy to help healthcare companies more effectively influence patient behavior, the company announced last week.
Sanofi Pasteur announced that the Food and Drug Administration approved the use of Menactra [meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine] as a booster vaccination against meningococcal disease in people ages 15 years through 55 years.